20 likes | 121 Vues
The AVERROES study was presented at the European Society of Cardiology Congress in Stockholm on August 31, 2010. This research assessed primary and secondary end points related to anticoagulant therapy in atrial fibrillation and highlighted important findings on bleeding events associated with treatment. The results offer critical insights for clinicians in managing patient safety and therapeutic efficacy in atrial fibrillation care.
E N D
AVERROES: Primary and secondary end points Connolly S. European Society of Cardiology 2010 Congress; August 31, 2010; Stockholm, Sweden.
AVERROES: Bleeding events Connolly S. European Society of Cardiology 2010 Congress; August 31, 2010; Stockholm, Sweden.